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Abstract 
Neuropathologically, Alzheimer's disease (AD) is characterized by neuritic 
plaques and neurofibrillary tangles. Evidence has suggested that a protein called 
B-amyloid (BA) is a major component of the neuritic plaques and may playa role 
in the neurodegeneration seen in AD. The cellular mechanisms by which BA 
induces neurotoxicity, however, are still unclear. Recent evidence suggests that the 
aggregational state of BA may be relevant to its neurotoxicity. Whether portions 
of the BA protein or the entire sequence produces neurotoxicity in neurons, 
however, remains a controversy. Still another controversy is whether BA is directly 
neurotoxic to neurons or whether it increases the vulnerability of neurons. Recent 
evidence reported by Doman, Kang, McCampbell and Kang, that injections of 
BA(25-35) with a low dose of ibotenic acid into the hippocampus did disrupt the 
acquisition of spatial learning in the rat, supports the vulnerability hypothesis. They 
suggest that the synergistic effect between BA and ibotenic acid may have produced 
the neurotoxic effect. In light of recent evidence (McCampbell, Peterson and 
Tinkler, unpublished) that injections of BA(1-42) alone did not disrupt the retention 
of a spatial learning task, in this study we assessed the increased vulnerability 
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hypothesis by co-injecting fiA(1-42) with a subthreshold dose of ibotenic acid into 
the hippocampus of male rats. Another problem related to fiA's neurotoxicity may 
concern the extent of hippocampal damage it produces. Therefore, we assessed the 
effects of multiple injections of fiA(1-42) and ibotenic acid into the hippocampus of 
male rats. Although preliminary, the results of this study conclude that co­
injections of fiA(1-42) and ibotenic acid do not disrupt the retention of a spatial 
learning task. 
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Alzheimer's Disease (AD) was first described by psychiatrist, Alois 
Alzheimer, in 1907 (9). Today, AD is the most common of the neurodegenerative 
diseases of aging (9). In the aging population of the world, AD represents a major 
health problem for which there is at present no effective treatment. 
Epidemiologic.al studies report that currently there are over 4 million people 
suffering from AD in the United States.alone. James Goldman and Luden Cote (8) 
estimate that AD accounts for about 70% of all age related cases of dementia. It 
afflicts an estimat~d 5-11 % of the population over 65 and more than 47 % over the 
age of 85 (8). 
Alzheimer's disease is clinically characterized by progressive impairments in 
memory, language, visuo-spatial skills and behavior (5). Typically, the 
neuropathology of AD is characterized by extracellular neuritic plaques and 
intracellular neurofibrillary tangles (13,19,17). Although a certain amount of 
neuritic plaques and neurofibrillary tangles can be found in normal aged people, 
they are not as dense or severe as seen in victims of AD. The cerebral cortex and 
hippocampus appear to be selectively targeted and are the primary sites of this 
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neuropathology. 
Recently, several studies have reported that a 39-42 amino acid long peptide, 
called B-amyloid (BA) is a major component of the neuritic plaques and may play 
a role in the neuronal degeneration of AD. This peptide is called BA because of 
its partial B-pleated structure (5). 
The amyloid peptide is derived from a larger amyloid transmembrane 
glycoprotein precursor (BAPP) that exists in several forms (15,18,25,32). Two 
forms contain Kunitz-type protease inhibitor (Kpn while two forms lack this 
domain. Mature BAPP consists of a long N-terminal (which lies outside the cell), 
a transmembrane portion (a segment that spans the membrane) and an intracellular 
C-terminal portion. The BA peptide resides in the transmembrane portion of the 
peptide (part of it lies within the membrane and part of it lies in the extracellular 
portion of the membrane). 
The BAPP gene is localized to chromosome 21 (27). Interestingly, Down's 
syndrome patients also have mutations of chromosome 21 and develop amyloid 
pathology (27). These findings have created increasing. interest in the role of 
amyloid in the pathology of AD. 
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To date two different enzymatic processing pathways of BAPP have been 
described. They are a and Bsecretasepathways (18). If enzymatic cleavage occurs 
along the a-secretase pathway the protein is cleaved within the BA fragment 
(preventing the formation of intact BA) and normal secreted BAPP (APP:J results. 
APP. can contain several functional domains including the KPI region, which is 
described as b.eing a serine protease inhibitor. This suggests that a normal function 
of secreted BAPP could be the regulation of protease activity. Other functional 
domains may stimulate cell proliferation, or regulate Ca2+ and neuroprotection. 
The fact that the intact BA fragment is generated and deposited in the brains 
of healthy aged humans, has encouraged researchers to investigate an alternative 
processing route that leaves the BA region intact. In this second secretory pathway, 
involving B-secretase, BAPP is cleaved at the amino terminus (beginning) of the BA 
sequence ~18). This means that intact BA is released into the extracellular fluid. 
The implication of these two pathways (a and B-secretase) is that not only 
does APPs have normal functions in healthy brains but the BA fragment is also 
generated in healthy humans. Therefore, high levels of BA in the cerebral spinal 
fluid (CSF) is not a straightforward indicator of AD. Realizing, however that the 
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alternative proteolytic pathway (B-secretase) is markedly increased in AD, it may 
serve as a risk factor in the development of the disease. 
Whether BA is directly neurotoxic, or produces neurotoxicity via an indirect 
mechanism , however, remains somewhat controversial. For example, BA 
fragments have been reported to be neurotoxic to hippocampal neurons in vitro (in 
cell culture)(~,14,24). Accumulating evidence suggests that BA's neurotoxic 
properties are presumably localized to amino acid residues 25-35 (12,26). As a 
result, it has been suggested that the accumulation of extracellular amyloid deposits 
may play a role in the neuronal degeneration that occurs in AD. 
Studies that have examined the effects of BA in vivo (in live animals) have 
resulted in apparent contradictions. Some studies, in vivo, have reported direct 
neurotoxicity of BA (11,17). For example, Kowall, Beal, Busciglio, Duffy and 
Yankner (1991) recently reported that intracerebral unilateral injections of20 fmol 
of BA(1-40) into the hippocampus of the adult rat brains caused a significant 
neuronal degeneration in the CAl layer of the hippocampus 0.5 - 1.0mm from the 
injection site. Other studies, however, report that BA is not directly neurotoxic in 
vivo (1,28,23). Stein-Behrens, Adams, Yen and Sapolsky recently reported that 
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injections of BA(25-35) in the hippocampus showed no evidence of neurotoxicity 
in the neurons (28). 
One possible explanation for these conflicting reports may be related to the 
self-aggregational properties of BA. Recently Cottman, Pike and Copani suggested 
that some of the discrepancies in the experiments may be due to the aggregational 
state of .BA (4). .BA peptide can exist in both soluble and insoluble forms, but 
toxicity appears to reside in insoluble aggregates, whereas soluble .BA may have 
little direct neurotoxicity. Cottman reports that BA protein (in vivo) exists primarily 
in an insoluble aggregated state within neuritic plaques. It has the property of 
spontaneous self-assembly into large, insoluble aggregates. Cottman also reported 
that in vitro only aggregated BA is associated with toxicity in developing 
hippocampus cultures. These findings suggest that in experiments done in vivo BA 
may be aggregating inside the injection needle, never entering the animals system. 
This may explain why some in vivo studies report that .BA is not neurotoxic to 
neurons. If .BA, therefore, is contributing to the progressive neurodegeneration of 
AD, the aggregated state of the protein may very well be relevant to its 
neurotoxicity. 
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The sequence of J3A (either portions of the peptide or the entire sequence) 
that produces neurotoxicity in neurons, however, is yet to be elucidated. Several 
studies have reported that the neurotoxic properties of J3A are localized to the amino 
acid residues 25-35 or 1-40 (7,12,26,29,31). In light of recent evidence suggesting 
that the soluble and insoluble states of J3A may playa role in its toxicity, a newly 
purified portion of the peptide (Abbott Laboratories, Abbott Park, Illinois) 
consisting of residues 1-42 has been under investigation. Presumably, J3A(1-42) 
has more hydrophobic regions on the peptide, making it more insoluble. It is 
readily dissolved in dimethylsulfoxide (DMSO). Intriguingly, this may solve some 
of the controversies described earlier with in vivo studies. If the aggregation of 
J3A can be prevented until the solution enters the animal's tissue, by dissolving the 
peptide in DMSO it will have an increased chance of exiting the needle. Recent in 
vitro studies also report that aggregated J3A(1-42) is neurotoxic to immature rat 
hippocampal neurons (21,22). For this reason, the present study used J3A(1-42) 
to examine the effects of the amyloid peptide. 
Currently, little is known about the behavioral effects that J3A injections may 
produce. Some investigators, however, have demonstrated that while J3A was not, 
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by itself neurotoxic to neurons in rats, mouse and human cortical neurons, it 
indirectly caused neurotoxicity.. According to these studies, fiA is rendering 
neurons more vulnerable to. outside insults such as excitotoxins or to glucose 
deprivation (3,6,10,16). For example, Dornan, Kang, McCambell and Kang (6) 
reported that bilateral injections of fiA(25-35) injections did not produce 
neurotoxicity in rat hippocampal neurons. Co-injections of fiA(25-35) with a 
subthreshold dose of ibotenic acid (an excitotoxin that causes Ca2+ influx), 
however, did produce lesions along with focal deposits in the hippocampus of rats. 
This fiA/ibotenic acid injection also disrupted the acquisition of spatial learning in 
the rat. This strongly suggests that fiA is exerting its neurotoxic effects not 
directly, but indirectly via an unknown mechanism. In that study, Dornan et al. 
suggest that the neurotoxic effect on hippocampal neurons and the subsequent 
disruption ... of the acquisition of spatial learning was a result of the increased 
vulnerability of neurons. They further suggest that the neurotoxicity may be 
produced by the synergistic effect of fiA(25-35) with ibotenic acid. 
In light of the above findings and recent evidence reported at the 5th annual 
Illinois Wesleyan Student Research Conference, that bilateral injections of fiA(1­
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42) alone does not produce a disruption of the retention of a spatial learning task, 
in the present study we further assessed the increased vulnerability hypothesis by 
co-injecting fiA(l-42) with a subthreshold dose of ibotenic acid into the 
hippocampus of male rats. 
Another problem related to 13A's neurotoxicity may concern the extent of 
hippocampal oamage it produces. Therefore, in this study we also assessed the 
effects of multiple injections of fiA(I-42) and ibotenic acid into the hippocampus of 
male rats. 
Method 
Animals and Groups 
A total of 29 male Long Evans rats were used in this study. They were 
housed individually on a 12L:12D cycle and maintained at 80-85 % of free body 
weight. They had free access to water except during behavioral testing. 
All animals were pre-tested on a partially baited 8-arm radial arm maze until 
the criterion of eating for at least three consecutive sessions was met. Seven animals 
did not meet this criterion and were not used in the study. Immediately following 
the screening test the remaining animals were randomly placed into three groups 
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for surgery. Each animal was anesthetized with sodium pentobarbital (40mg/kg) 
and received four bilateral injections throughout the hippocampus. A peptide 
corresponding to the first 42 amino acids of BA [BA(1-42)] was synthesized, 
purified and dissolved in dimethylsulfoxide (DMSO). This vehicle was used in 
all control injections as well. The following injections were administered in a 1 J,LL 
volume via a 1 J,LL Hamilton syringe: Group 1, BA(1-42) 7 nmol/injection per side 
+ 4 nmol/injection per side of ibotenic' acid (mO); Group 2, scrambled BA peptide 
7 nmol/injection per side + 4 nmol/injection per side of mo; Group 3, rno 4 
nmol/injection pet side. In order to prevent back flow and minimize tissue damage, 
the injection took place over approximately 3 minutes and the syringe was left in 
place after the injection for another 3 minutes. 
Surgery 
After the animals were anesthetized, they were placed into a stereotaxic 
apparatus. A stereotaxic apparatus is a device containing a holder that fixes the 
animal's head in a standard position and a carrier that moves a cannula (hollow 
tube) or syringe in all three axes of space. By empirically determining coordinates 
using a stereotaxic atlas, and experimenter may locate and insert a cannula or 
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syringe to a specific part of the brain without serious damage to the overlying 
tissue. As can be seen from Table 1, the stereotaxic coordinates for this experiment 
were empirically determined using the atlas of Paxinos and Watson (20). 
Insert Table 1 about here 
Apparatus and Behavioral Testing 
In order to asses the retention of spatial learning in the rats, we tested them 
on a partially baited 8-arm radial arm maze (RAM). The RAM consists of a center 
platform about two and a half feet across with eight(six inch wide, two and a half 
feet long) arms radiating from it. At the end of each arm there will be a white 
painted plastic cup to hold reinforcement for the animals. Prior to actual testing, 
all animals were given at least 5 days where the reinforcer (Froot Loops) was 
liberally scattered on the RAM and the animal allowed to explore (habituation). 
Following this phase, each subject was assigned to one of three maze orientations 
and a random set of 5 arms which served as the baited set. This orientation 
remained the same throughout the entire experiment. All behavioral testing was 
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conducted blind (the experimenters did not know the condition of the rat). The 
session began when the experimenter placed the subject on the center of the 
platform. The animal was then allowed to choose among the arms until it either 
successfully completed the test (obtains all 5 rewards) or until 10 minute had 
elapsed. If the subject did not make a partial entry (approximately 2/3 of the way 
down each arm is a piece of tape, if the subject crosses this line it will be 
considered a partial entry) within the 'first 5 minutes the session was terminated. 
The following parameters were reported at each session: the number of arms 
revisited (total errors); correct errors, repeated entry into baited arms; incorrect 
errors, repeated entry into non-baited arms; reference memory, entry into arms 
that are never baited. Other behaviors of the subjects were also be reported such 
as, urination and defecation. All scores were be summed and averaged over every 
7 day block. 
Results 
The present study used an analysis of variance (ANOVA) test to qualitatively 
examine the groups. Specifically, the ANOVA was a split plot mixed design with 
blocks as the repeated measure and injection condition as the between group 
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measure. Multiple ANOVA's were performed on total errors, correct errors, 
incorrect errors, reference memory errors and percent correct choice. Qualitative 
examination of multiple injections of BA(1-42) + ibotenic acid reveal no significant 
effects when compared to controls. Interestingly, the animals in all three groups 
not only retained the learning from the pre-surgery task, but also improved by the 
end of the fou~th block (Figures 1-5). All three groups had a higher percentage of 
correct choices by the fourth block (Figure 1) and all error parameters that were 
recorded were drastically reduced by the fourth block (Figures 2-5). 
Insert Figures 1-5 about here 
Discussion 
The-results of the present study indicate that multiple injections of BA(1-42) 
with a subthreshold dose of ibotenic acid does not significantly disrupt the retention 
of a spatial learning task in male rats. In contrast to recent reports (7,29), this 
study indicates that the neurotoxicity of BA may not reside in the amino acid 
residues 1-42. Intriguingly, in the study done by Doman et al. (6) co-injections of 
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BA(25-35) + rna did produce a deficit in a spatial learning task. It is interesting 
to note, however, that Dornan eta!. assessed the effects of the BA injections on the 
acquisition of spatial learning while the present study investigated the retention of 
the task. The acquisition of learning is the initial learning done by the animals 
while the retention of learning refers to what the animal has already learned. 
In interpreting the data there are several factors to be considered. First of 
all, the study lacked two control groups. Dimethylsulfoxide (DMSO) was used as 
a vehicle for all of the conditions. Therefore, one group should have been injected 
with DMSO alone to show that it has no neurotoxic effects by itself. The second 
control group that should have been added was a group injected with scrambled 
peptide. This would reveal any effect that a peptide, in general, would have on the 
animal's behavior. Due to the high mortality rate resulting from multiple injections 
(about 30%) and to the limited number of animals available, these control groups 
were eliminated from the study. 
Also related to the high mortality was the small statistical samples: Group 
1, n=5; Group 2, n=4; Group 3, n=4. Small statistical samples may lead to 
misinterpreted data. They can either magnify random trends or "hide" behavioral 
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effects that may be significant. 
At present histological examinations have not been performed. Histological 
assessment can verify injection sites as well as provide information as to 
hippocampal damage. Therefore, the results of this study must be considered 
preliminary and acknowledged with caution. 
Finally,. evidence has suggested that the sensitivity of the radial arm maze to 
measure the behavioral effects of hippocampal damage is controversial (2). 
According to Neal Cohen (2), the hippocampal system plays a critical role in 
mediating declarative memory. Declarative memory is a memory system that 
consists of a relational form of representation and has the property of flexibility. 
For example, when a person finds their way from one point to another by using a 
map, they are presumably using declarative memory. In contrast, a form of 
memory that operates independent of the hippocampal system, is procedural 
memory (2). Procedural memory supports a fundamentally inflexible form of 
representation. For example, riding a bike or driving a car would be procedural 
memory. If the radial arm maze task is used as a behavioral measure to assess 
hippocampal damage, then its efficiency is determined by how well it can tap 
•
 
Multiple injections of BA(I-42) + rna 
18 
declarative memory. 
While the rat is running the maze, it must learn to minimize the number of 
arms that it enters due to the time constraint in which it is placed. Therefore, the 
animal must identify arms that contain the reinforcer while keeping track of arms 
that have already been visited. The rat may accomplish this by using spatial 
representations of extraneous cues surrounding the maze. These abilities may be 
dependent on declarative memory. It is'possible, however, that the animals develop 
a "strategy" to complete the maze. They may enter one arm and then proceed to 
complete the maze in systemic circular fashion. This type of strategy is related to 
procedural memory. Therefore, if the animal runs the maze using a "strategy" it 
may decrease the reliability of the radial arm maze to effectively measure the 
behavioral effects of hippocampal damage. 
While the results of the present study did not produce any significant results, 
the extent of hippocampal damage that is required to elicit the behavioral effects of 
BA is still unclear. Therefore, further investigation using multiple injections of 
various sequences of BA may be required to better understand the role of BA in the 
pathogenesis of AD. As others have suggested BA may be involved in promoting 
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the vulnerability of otherwise heathy neurons to excitotoxic damage (3,6,10,16). 
In contrast to the results of this study, BA may exert its neurotoxic effect of 
hippocampal ne~rons indirectly via it Ca2+ dependent mechanism. In a recent 
study done by Weiss, Pike and Cotman (29), the Ca2+ channel blocker, 
nimodopine, attenuated BA toxicity (residues 1-40 and 1-42) to cortical neurons in 
culture. They also reported that glutamate receptor antagonists, such as MK-801, 
had no effect ofBA neurotoxicity, This ,Suggests that voltage-sensitive Ca2 + channel 
blockers may be required tet.attenuate BA injury. Therefore, further research on 
BA may include ;investigating the behavioral effects of nimodopine following 
injections of BA as well as the interaction of stress hormones on the BAPP induced 
neurotoxicity. 
These studies may allow for a better understanding of Alzheimer's disease 
and the role of BA. Critical to this work, however, is the development of an animal 
model of AD that mimics the profound impairment in memory characteristics found 
in human AD patients. It is with this knowledge that new approaches to a treatment 
for the disease will be possible. 
• 
Multiple injections of flA(I-42) + rna 
20 
References 
[1] Clemens, J.; Stephenson,D. (1992). Implants containing a-Amyloid protein are 
not neurotoxic to young and old rat brain. NeurobiQlogy Qf Aging, 
13, 581-586. 
[2]	 Cohen, N. and Eichenbaum. (1993). Memory, amnesia, and the hippocampal 
system..MIT Press, Cambridge, Massechusetts. 
[3]	 Copini, A; Koh, Y and Cotman, C. (1991). fl-amyloid increases neuronal 
susceptibility to injury by glucose deprivation. NeurQreport, 2, 763-765. 
[4]	 Cotman, C.W.;; Pike,C.J.; Copani, A. (1992). a-Amyloid neurotoxicity: A 
discussion of in vitro findings. NeurQbiology of Aging, 13, 587-590. 
[5] Crawford, F. and Goate, A. (1992). Alzheimer's disease untangled. Bio Essays, 
14, 727-734. 
[6]	 Doman, W.; Kang, D.; McCampbel, A. and Kang, E. (1993). Bilateral 
injections of flA(25-35) + rna into the hippocampus disrupts acquisition of 
spatialleaming in the rat. Neuroreport,~, 165-168. 
[7]	 Giordano, T; Pan, 1.; Monteggia, L.; Holzman, T.; Synder, S.; Krafft, G.; 
Ghanbari, H. and Kowall, N. (1994). Similarities between fl-Amyloid 
•
 
Multiple injections of BA(1-42) + rna 
21 
peptides 1-40 and 40-1: Effects on aggregation, toxicity in vitro, and injection 
in young and aged rats. Experimental Neurology, 125, 175-182. 
[8] Goldman, 1. and Cote. (1991). Aging of the brain: dementia of the Alzheimer's 
type. In Kandel, E.; Schwartz, J.; Fessel, T. (Eds.), Principles of 
Neuroscience, New York, Elsevier. 
[9]	 Katzman, ·R. and ThaI. (1989). Neurochemistry of Alzheimer's disease. In 
Siegel et aI. (Eds.), Basic Neurochemistry: molecular, cellular, and medical 
aspects 4th edition. New York: Raven Press. 
[10]	 Koh, 1.; Yang, L. and Cotman, C. (1990). fi-Amyloid protein increases the 
vulnerability of cultured cortical neurons to excitotoxic damage. Brain 
Research, 533, 315-320. 
[11] Kowall, N.; Beal,F; Busciglio,J.; Duffy,L.; Yankner,B. (1991). An in vitro 
model for the neurodegenerative effects of B amyloid and protection by 
substance P. Procedures of the Natural Academy of Science, 88, 7247-7251. 
[12] Kowall, N.W., McKee, A.C., Yankner, B.A. and Beal, M.F. (1992). In vivo 
neurotoxicity of beta-amyloid [B(l-40)] and the 13(25-35) fragment. 
Neurobiology of Aging, 13, 537-542. 
•
 
Multiple injections of fiA(1-42) + rna 
22 
[13]	 Lu, Q. and Wood, J. (1993). Functional studies of Alzheimer's disease tau 
protein. The Journal of Neuroscience, 13, 508-515. 
[14] Malouf, A. (1992). Effect of beta amyloid peptides on neurons in hippocampal 
slice cultures. Neurobiology of Aging, 13., 543-551. 
[15] Mattson,M. ;Barger,S. ;Chang,B. ;Leiberburg,1.; Smith-Swintsky,V,; Rydel,R. 
(1993). ~-Amyloid precursor protein metabolites and loss ofneuronal calcium 
homeostasis in Alzheimer's disease Trends in Neuroscience, 16, 409-414. 
[16] Mattson M.; Cheng, B.; Davis, D.; Bryant, K. Lieberburg, 1. and Rydel, R. 
(1992). fi-amyloid protein destabilized calcium homeostasis and render human 
cortical neurons vulnerable to excito-toxicity. Journal of Neuroscience, 12, 
376-389. 
[17] McKee, A.C., Kosik, K.S. and Kowall, N. W. (1991). Neuritic pathology 
and dementia in Alzheimer's Disease. Annals of Neurology, 30, 156-165. 
[18]	 Mullan, M.; Crawford,F. (1993). Genetic and molecular advances in 
Alzheimer's disease. Trends in Neuroscience, 16, 398-402. 
[19] Murphy, M.	 (1992). The molecular pathogenesis of Alzheimer's disease: 
Clinical prospects. Lancet, 340, 1512-1515. 
•
 
Multiple injections of BA(1-42) + rna 
23 
[20] Paxinos, G, and Watson, C. (1986). The rat brain in stereotaxic coordinates, 
Academic Press, Sydney. 
[21] Pike, C.; Walencewicz, A.; Glabe, C. and Cotman,	 C. (1991). Aggregation-
related toxicity of synthetic B-amyloid protein in hippocampal cultures. Eur. 
Journal of Pharmacology, 207, 367-368. 
[22] Pike, C.; .Walencewicz, A.; Glabe, C. and Cotman, C. (1991) In vitro aging 
of B-amyloid protein causes peptide aggregation and neurotoxicity. Brain 
Research, 563, 279-282. 
[23] Podlinsny,	 11.; Stevenson, D.; Matthew, P.; Lieberburg, 1.; Clemons, 1.; 
Selkoe, D. (1992). Synthetic amyloid a-protein fails to produce specific 
neurotoxicity in monkey cerebral cortex. Neurobiology of Aging,13, 
561-567. 
[24] Price,-D.L.; Borchelt,D.; Walker,L.; Sisodia, S. (1992). Toxicity of synthetic 
AB peptides and modeling of Alzheimer's Disease. Neurobiology of 
Aging, 13, 623-625. 
[25] Selkoe, D. (1993). Physiological production of the a-amyloid protein and the 
mechanism of Alzheimer's disease. Trends in Neuroscience, 16, 403-408. 
24 
Multiple injections of BA(I-42) + rna 
[26] Simmons, M.A. and Schneider, C.R. (1993). Amyloid B peptides act directly 
on single neurons. Neuroscience Letters, 150, 133-136. 
[27]	 St George-Hyslop, P. H.; Tanzi R.; Polinsky, J. Haines, L.; Watkins, P.; 
Myers, R.; Feldman, R.; Pollen, D.; Drachman, D.; Growdon, 1.; Bruni, 
J.; Salmon, D.; Frommelt, P.; Amaducci, L,; Sorbi, S.; Piancentini, S.; 
Stewart, G.; Hobbs, W,; Conneally, P.; and Gusella, J. (1987). The genetic 
defect causing familial Alzheimer's disease maps on chromosome 21. 
Science, 235, 885-890. 
[28]	 Stein-Behrens, B.; Adams, K.; Yeh, M.; Sapolsky, R. (1992). Failure of 
beta-amyloid protein fragment 25-35 to cause hippocampal damage in the rat. 
Neurobiology of Aging, 13, 577-579. 
[29]	 Ueda, K; Fukui, Y. and Kageyama, H. (1994). Amyloid B protein-induced 
neuronal cell death: neurotoxic properties of aggregated amyloid B 
protein. Brain Research, 639, 240-244. 
[30] Weiss, J.; Pike, C. and Cotman, C. (1994). Ca2+ channel blockers attenuate 
B-Amyloid peptide toxicity to cortical neurons in culture. Journal of 
Neurochemistry, 62, 372-375. 
25 
Multiple injections of 13A(1-42) + rno 
[31]	 Yankner, A.; Duffy, K. and Kirschner, A. (1990) Neuroprotective and 
neurotoxic effects ofamyloid 13 protein: reversal by tachykinin neuropeptides. 
Science, 250. 279-282. 
[32]	 Yankner, B.; Mesulum, M. M. (1991). a-Amyloid and the pathogenesis of 
Alzheimer's disease. New England Journal of Medicine, 325, "1849-1855. 
Table 1 
Hippocampal Injection Coordinates 
Direction 
...- Injection # AP ML DV 
1 4.6 2.3 3.3 
2 4.6 3.3 3.3 
3 5.2 4.6 5.0 
4 5.2 4.6 5.5 
Note. The table sho'Ws the hippocampal injection coordinates 
empirically determined using the atlas of Paxinos and Watson. AP= 
anterior poster-ior I ML= medial lateral and DV= dorsal ventral. The 
injections were bilateral giving each rat a total of eight 
injections. 
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Figure Caption 
Figure 1. Group differences in the mean percent correct choices over blocks 2-3 
(1 block= 7 sessions). 
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Figure Caption 
Figure 2. Group differences in the mean number of correct errors committed over 
the blocks (l block= 7 sessions). Correct errors are entry into arms that the rat 
has already obtained food in the same session. Vertical lines indicate the standard 
errors. 
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Figure Caption 
Figure 3. Group differences in the mean number of incorrect errors committed 
over the blocks (1 block+ 7 sessions). Incorrect errors are repeated entry into 
arms of the maze that are never baited. Vertical lines indicate the standard errors. 
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Figure Caption 
Figure 4. Group differences in the mean number of reference memory errors made 
over the blocks (1 block+ 7 sessions). A reference memory error is an entry into 
an arm of the maze that is never baited. Vertical lines indicate the standard errors. 
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Figure 5. Group differences in the mean number of total errors committed over the 
blocks (1 block + 7 sessions). Total errors include correct, incorrect and reference 
memory errors. Vertical lines indicate the standard errors. 
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